Can a video game boost HPV shots? new study tests it
NCT ID NCT06162676
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a short health game designed for parents and their 11-14 year old children to encourage HPV vaccination. Researchers enrolled 133 families with unvaccinated kids to see if the game was easy to use and acceptable. The goal was to learn if this low-cost approach could help more children get vaccinated against HPV-related cancers.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- HPV game (a brief health game for parent-child dyads)
- What this could lead to
- If successful, this game could offer a low-cost way to boost HPV vaccination rates and reduce cancer disparities.
- What could go wrong
- This is a small pilot study focused on feasibility, not effectiveness. The game may not change vaccination behavior in larger, more diverse groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
133 people
The number who actually took part.
- Started
-
Apr 2024
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
11 to 14 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Youth: (1) 11-14 years old; (2) have not received the 1st dose of HPV vaccine; (3) speak and read English * Parent: (1) are the parent/legal guardian of the participating child; (2) ≥ 18 years old; (3) speak English or Spanish; (4) own a smartphone; (5) agree to participate in the research activities at study sites; (6) agree to receive text messages. * Healthcare providers: (1) ≥ 20 years old; (2) speak English or Spanish); (3) work at study sites Exclusion Criteria: * Individuals are unable to comprehend the consent or assent forms due to cognitive issues
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Michigan State University
East Lansing, Michigan, 48824, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine shield transplant patients from shingles?
- Tweets that tell a story: a new approach to boosting HPV vaccination
- Can a daily supplement help the body fight off HPV?
- Which COVID-19 shot causes fewer side effects? new study compares novavax and pfizer
- At-Home HPV tests could save lives of women with HIV
- New vaccine for moms could shield babies from whooping cough